Guardant Health (GH) Payables (2017 - 2026)

Guardant Health has reported Payables for 10 years, with the latest figure at $93.5 million in Q2 2026.

• Quarterly Payables rose 108.73% year-over-year to $93.5 million in Q2 2026, while the trailing twelve-month figure through Jun 2026 was $93.5 million (up 108.73% YoY) and the FY2025 annual result came in at $54.4 million, up 41.22% from the prior year.
• Payables climbed to $93.5 million in Q2 2026 per GH's latest filing, from $75.0 million in the prior quarter.
• Over five years, Payables peaked at $205.3 million in Q3 2023 and troughed at $15.5 million in Q3 2024.
• A 5-year average of $77.4 million and a median of $47.3 million in 2025 frame the typical range for Payables.
• The sharpest annual moves came in 2023 and 2024: Payables soared 491.17% in 2023, then slumped 92.46% in 2024.
• Over 5 years, Payables stood at $175.8 million in 2022, then slumped by 70.57% to $51.7 million in 2023, then declined by 25.49% to $38.6 million in 2024, then soared by 41.22% to $54.4 million in 2025, then soared by 71.77% to $93.5 million in 2026.
• According to Business Quant data, Payables over the past three periods registered $93.5 million, $75.0 million, and $54.4 million for Q2 2026, Q1 2026, and Q4 2025 respectively.